Nucleotidyl cyclase activity of recombinant soluble guanylyl cyclase

por Rauch, Kerstin, Stasch, Johannes-Peter, Kaever, Volkhard, Seifert, Roland
Publicado 2009

Biomarkers in two different animal models of pulmonary arterial hypertension (PAH) under treatment with a cGMP enhancing substance

por Grupe, Julia, Neumann, Andrea, Stasch, Johannes-Peter, Leineweber, Kirsten
Publicado 2011

Relaxant effect of BAY 41-2272 and BAY 58-2667 in the gastrointestinal tract of apo-sGC mice

por Cosyns, Sarah, Stasch, Johannes-Peter, Brouckaert, Peter, Lefebvre, Romain A
Publicado 2011

Comparison of different vasodilators, endothelin antagonist, PDE5 inhibitior and sGC stimulators, in an animal model of secondary pulmonary hypertension: effects on “desaturation”...

por Becker, Eva Maria, Stasch, Johannes-Peter, Bechem, Martin, Truebel, Hubert
Publicado 2011

Evidence for two catalytic centers and Mn(2+) as physiological cofactor of soluble guanylyl cyclase

por Beste, Kerstin Yvonne, Stasch, Johannes-Peter, Kaever, Volkhard, Seifert, Roland
Publicado 2011

NO-independent stimulation or activation of soluble guanylyl cyclase during early reperfusion limits infarct size

por Bice, Justin S., Keim, Yvonne, Stasch, Johannes-Peter, Baxter, Gary F.
Publicado 2014

Chronic Activation of Heme Free Guanylate Cyclase Leads to Renal Protection in Dahl Salt-Sensitive Rats

por Hoffmann, Linda S., Kretschmer, Axel, Lawrenz, Bettina, Hocher, Berthold, Stasch, Johannes-Peter
Publicado 2015

The uremic retention solute p-cresyl sulfate alters NO signal transduction by alteration of the soluble guanylate cyclase redox state

por Meijers, Björn KI, Meye, Constanze, Stasch, Johannes-Peter, Gross, Peter, Evenepoel, Pieter
Publicado 2009

Pharmacological preconditioning with the guanylate cyclase activator cinaciguat (BAY 58-2667) protects against reperfusion injury after cardiopulmonary bypass

por Radovits, Tamás, Korkmaz, Sevil, Loganathan, Sivakkanan, Stasch, Johannes-Peter, Karck, Matthias, Szabó, Gábor
Publicado 2009

Chronic activation of heme free soluble guanylate cyclase leads to cardio-renal protection in experimental hypertension

por Hoffmann, Linda S, Kretschmer, Axel, Lawrenz, Bettina, Hucke, Andreas, Hocher, Berthold, Stasch, Johannes-Peter
Publicado 2013

Antihypertrophic actions of NO-independent soluble guanylyl cyclase (sGC) ligands BAY 41-2272 and BAY 58-2667 in vitro

por Ritchie, Rebecca, Irvine, Jennifer, Love, Jane, Horowitz, John, Stasch, Johannes-Peter, Kemp-Harper, Barbara
Publicado 2009

Activation of heme-free soluble guanylate cyclase with cinaciguat has beneficial cardiorenal actions when added to furosemide in experimental heart failure

por Boerrigter, Guido, Costello-Boerrigter, Lisa C, Cataliotti, Alessandro, Stasch, Johannes-Peter, Burnett, John C
Publicado 2011

Increases survival by apo-sGC activation via post-stroke blood brain barrier stabilisation and anti-inflammation

por Langhauser, Friedericke, Hauck, Annegret, Radermacher, Kim, Stasch, Johannes-Peter, Kleinschnitz, Christoph, Schmidt, Harald HHW
Publicado 2013

Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation

por Hoffmann, Linda Sarah, Schmidt, Peter Michael, Keim, Yvonne, Schaefer, Stefan, Schmidt, Harald, Stasch, Johannes-Peter
Publicado 2009

Cardioprotective effects in aged spontaneously hypertensive rats due to chronic stimulation/activation of sGC without hypotension

por Jones, Emma S, Kemp-Harper, Barbara K, Stasch, Johannes-Peter, Schmidt, Harald HHW, Widdop, Robert E
Publicado 2009

The Soluble Guanylate Cyclase Activator BAY 58-2667 Protects against Morbidity and Mortality in Endotoxic Shock by Recoupling Organ Systems

por Vandendriessche, Benjamin, Rogge, Elke, Goossens, Vera, Vandenabeele, Peter, Stasch, Johannes-Peter, Brouckaert, Peter, Cauwels, Anje
Publicado 2013

The soluble guanylate cyclase activator BAY 58-2667 protects against morbidity and mortality in endotoxic shock by recoupling organ systems

por Vandendriessche, Benjamin, Rogge, Elke, Goossens, Vera, Vandenabeele, Peter, Stasch, Johannes-Peter, Brouckaert, Peter, Cauwels, Anje
Publicado 2013

Urinary cGMP concentrations after exposure to radio-contrast media in patient at risk for contrast media induced nephropathy (CIN) predicts 90-day morbidity and mortality

por Hocher, Berthold, Heunisch, Fabian, von Einem, Gina-Franziska, Alter, Markus, Keim, Yvonne, Stasch, Johannes-Peter
Publicado 2013

Fluorescence Dequenching Makes Haem-Free Soluble Guanylate Cyclase Detectable in Living Cells

por Hoffmann, Linda S., Schmidt, Peter M., Keim, Yvonne, Hoffmann, Carsten, Schmidt, Harald H. H. W., Stasch, Johannes-Peter
Publicado 2011

Inhibition of the TGFβ signalling pathway by cGMP and cGMP‐dependent kinase I in renal fibrosis

por Schinner, Elisabeth, Wetzl, Veronika, Schramm, Andrea, Kees, Frieder, Sandner, Peter, Stasch, Johannes‐Peter, Hofmann, Franz, Schlossmann, Jens
Publicado 2017